15:30pm Chair Introduction

Matthew Hewitt, Executive Director Scientific Services, Cell and Gene Therapy, Charles River Laboratories

15:35am Presentation: Pioneering a New Wave of Gene-Agnostic Gene Therapy

• Recent advancements in gene therapy
• Overview of retinal degenerative disease
• Novel, gene-agnostic optogenetics approach to treat retinal degenerative disease
• Clinical program overview and next steps

Samarendra Mohanty, Co-Founder and President, Nanoscope Therapeutics

16:05am Presentation:  Present and Future of Cell and Gene Therapies

• Overview of cell therapy progress to date
• Critical technological advancements driving robust development, manufacturing and testing
• Leveraging a discovery platform to engineer a TCR-T cell therapy product to treat AML
• Future direction of the cell therapy industry

Robert Keefe, Chief Development Officer, BlueSphere

16:35pm Closing Panel with Q&A

With all session participants